Chris DeMuth Jr., is the founder of Rangeley Capital. Chris runs the investing group Sifting the World, in which he shares his best ideas, deep research, extensive resources and real time updates ...

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor.

Chris DeMuth, Jr. shares some of his current top picks. Arbutus Biopharma is a promising investment due to its potential litigation value from IP claims against Pfizer and Moderna related to COVID ...

King Charles: Don’t Mention the (Hundred Years’) War Mamie and Other Van Dorens Rubio Warns That China Can ‘Shut Down’ Panama Canal: ‘Direct Threat’ Christopher DeMuth has written ...

As Rangeley Capital's Chris DeMuth summed up after the decision. The Supreme Court’s denying cert is the last major legal challenge to Liquidia’s ability to get to market next spring.

Although technical, it was an important win for Arbutus in the claim. Rangeley Capital’s Chris DeMuth told Seeking Alpha: “Today's claim construction order was virtually identical with Arbutus ...

"HMLP has elected to be treated as a C-Corporation for U.S. federal income tax purposes (our investors receive a Form 1099 and not a Schedule K-1) Distributions we pay to U.S. unitholders will be ...